Open new Covid treatment criteria, Department of Medicine adjusts drug dispensing to suit each level of illness divided into asymptomatic patients, mild symptomatic patients, and mildly symptomatic patients But there is a risk of co-morbidities. and seriously ill
Open new Covid treatment criteria, Department of Medicine adjusts drug dispensing to suit each level of illness divided into asymptomatic patients, mild symptomatic patients, and mildly symptomatic patients But there is a risk of co-morbidities. and seriously ill
updatenew covid treatment criteria from the “Medical Department” to fit the epidemic situation of “Covid-19” The latest wave of 2022 and to be more suitable for each level of covid patients. Previously, Dr. Surachoke Tangwiwat, Deputy Secretary-General of the Food and Drug Administration (FDA), said that registrationMolnupiravir andPaxlovidused tocure for covid-19 In Thailand, it is also registered for use in emergencies as well as around the world.
any hospital both public and private If the drug is prescribed toCOVID-19 patients Must meet medical standards according to treatment guidelines issued by the Medical Department.
The “Medical Department” has issuedGuidelines for medical practice, diagnosis, care and prevention of infection in hospitals. Coronavirus disease 2019 (COVID-19) cases for doctors and public health personnel Revised Edition No. 24 Date 11 Jul 2022
by the cooperation of the faculty Experts from various departments and representatives of the medical team on the job site in caring for COVID patients has reviewed and adjusted patient care guidelines According to academic information in countries and abroad as follows:
Related news :
Treatment for people infected with COVID-19 can be divided into groups according to the severity of the disease and risk factors in 4 cases as follows:
1. Patients who do not have symptoms or are well
a group of infected but no symptoms provide outpatient treatment by isolating HI at home, treating symptoms according to the discretion of the doctor. Do not give antiviral drugs such as favipiravir. Because most of them disappear on their own. May consider giving Andrographis paniculata at the discretion of the physician
2. Patients with mild symptoms no pneumonia
It was a group of patients with mild symptoms, not severe, with no risk factors for severe disease/major comorbidities. and examined radiographs of the lungs found normal In this case, it may be consideredfavipiravir“You should start the medicine as soon as possible.
If infection is detected when the patient has symptoms for more than 5 days and the patient has no symptoms or has few symptoms Antiviral medication may not be necessary. Because the patient will heal on their own without complications.
3. Patients with mild symptoms but at risk of severe disease / having co-morbidities
A group of patients with mild symptoms, not severe, but with risk factors. have underlying disease or patients without risk factors but with mild to moderate pneumonia also do not need oxygen
This group recommends only one antiviral drug, which should be started within 5 days of the onset of symptoms to be effective. without any risk factors “Favipiravir”
- If there is 1 risk factor, the order of administration is molnupiravir. , Remdesivir, Nermatrolvir/ritonavir (Paxlovid) and Favipiravir.
- If there are two or more risk factors, remdesivir is given. or nermatrelvir/ritonavir (Paxlovid) or molnupiravir
The order of drug administration Considering drug availability in the country, drug efficacy in reducing morbidity, mortality, ease of administration and drug prices, current data Nerma Trailvir/Ritonavir most efficient but has the highest price Favipiravir part does not reduce the rate of serious illness but can help reduce symptoms If given early in the risk group
*Note: The risk factors for severe disease are age over 60 years old, COPD, other lung diseases, chronic kidney disease, cardiovascular disease, congenital heart disease, stroke, and diabetes mellitus. Uncontrollable, obesity, cirrhosis, low immunity and HIV-infected
4. Confirmed patients with pneumonia severe pneumonia
The group of patients with severe symptoms was diagnosed with pneumonia. Severe pneumonia, no later than 10 days following symptoms and oxygen exposure are recommended.RemdesivirAs soon as possible for 5 to 10 days depending on clinical symptoms. Patients should be closely monitored along with thecordicosteroid medication” (corticosteroid)
In addition, Dr. Thares Krasanairawiwong Director-General of the Department of Health Service Support (SorPorPor.) stated that now the situation of the Covid-19 epidemic changed from the original Therefore, there is a guideline forPatients with no symptoms or few symptoms Provide outpatient treatment (OPD) without hospitalization. Now there is a consideration to cancel the announcement to establish a temporary medical facility that was previously established in the amount of more than 100 places.
But recently, there are reports that some private hospitals are now Informed that there are more patients. Therefore, in order not to disturb the usual hospital bed Therefore, we are requesting SorPor.Sor. to review the cancellation of this announcement first. to wait to see the situation for 1-2 months, which is now proposing to the chairman of the hospital whether to expand this section or not,” said Dr. Thares.